Angiotensin-(1–7) is reported to suppress the acylation of the retinal protein O-GlcNAc via EPAC/Rap1-dependent O-GlcNAc transferase, suggesting the contribution of Rap1 to diabetic retinopathy [35]. This evidence concerns the gene RAP1A and diabetic retinopathy.